Precision BioSciences (Nasdaq: DTIL) has received approval in Hong Kong to begin clinical trials evaluating a gene editing ...

Researchers from presented preclinical data for AVX-70371, a novel therapeutic vaccine being developed for the treatment of chronic hepatitis B virus (HBV) infection. Therapeutic hepatitis B vaccine ...

Hepatitis B virus (HBV) has a narrow host range, mainly infecting hominoids. A new study reveals the structural differences in the liver cell receptor (NTCP) between humans and monkeys ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior ...

A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior ...

As the Hepatitis B Virus (HBV) spreads across Nigeria, drug merchants are selling untested alternative medicines to patients, ...

Hepatitis B is a lifelong infection of the liver caused ... Because the virus can hide in human liver cells by integrating itself into the human genome, it is extremely difficult to cure.

Background To determine clinical-pathologic variables in patients with a new diagnosis of hepatocellular carcinoma (HCC) and underlying hepatitis B vs. C infection. Methods Patients presenting to ...